Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Jennifer E. Woodell-May"'
Publikováno v:
Journal of Orthopaedic Research. 38:253-257
Understanding the molecular drivers and feedback loops of osteoarthritis (OA) may provide future therapeutic strategies to modulate the disease progression. The current paradigm of OA is evolving from a purely mechanical disease caused by cartilage w
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 2726, p 2726 (2021)
International Journal of Molecular Sciences
International Journal of Molecular Sciences
Osteoarthritis (OA) is a progressive degenerative disease that manifests as pain and inflammation and often results in total joint replacement. There is significant interest in understanding how intra-articular injections made from autologous blood o
Autor:
Ryan Foreman, Mark Klaassen, Edith Cullen, William P. King, Jason Hix, Jennifer E. Woodell-May, Krista Toler
Publikováno v:
BioResearch Open Access, Vol 6, Iss 1, Pp 151-158 (2017)
BioResearch Open Access
BioResearch Open Access
Osteoarthritis (OA) is a progressive and degenerative disease, which may result in significant pain and decreased quality of life. Recent updates in our understanding of OA have demonstrated that it is a whole joint disease that has many similarities
Publikováno v:
Journal of Orthopaedic Research. 35:2260-2268
Current osteoarthritis (OA) research searches for treatments that modify the course of disease progression. Autologous Protein Solution (APS) is derived from whole blood and is a unique autologous therapy that contains high concentrations of white bl
Autor:
V. Vedi, Jennifer E. Woodell-May
Publikováno v:
Osteoarthritis and Cartilage. 28:S156
Autor:
Matthew L. Tan, William J. King, Jennifer E. Woodell-May, Michael P. Murphy, Zachary R. Welch, James M. McKale, Matthew J. Swift
Publikováno v:
BioResearch Open Access, Vol 4, Iss 1, Pp 417-424 (2015)
BioResearch Open Access
BioResearch Open Access
Critical limb ischemia (CLI) is a terminal disease with high morbidity and healthcare costs due to limb loss. There are no effective medical therapies for patients with CLI to prevent amputation. Cell-based therapies are currently being investigated
Autor:
Andrea M. Matuska, William P. King, Mark Klaassen, Jennifer E. Woodell-May, Krista O'shaughnessey, Jacy C. Hoeppner, Christian Lattermann, Christopher C. Kaeding, Jack Farr
Publikováno v:
Journal of Orthopaedic Research. 32:1349-1355
The objective of this clinical study was to test if blood from osteoarthritis (OA) patients (n = 105) could be processed by a device system to form an autologous protein solution (APS) with preferentially increased concentrations of anti-inflammatory
Publikováno v:
Journal of Orthopaedic Research. 31:1929-1935
Osteoarthritis (OA) is characterized by deterioration of articular cartilage driven by an imbalance of pro- and anti-inflammatory cytokines. To address the cartilage deterioration observed in OA, an autologous protein solution (APS) has been develope
Autor:
Jennifer E. Woodell-May, Krista O'shaughnessey, Andrea M. Matuska, Zachary R. Welch, Megan Oyster, Jacy C. Hoeppner
Publikováno v:
Journal of Orthopaedic Research. 29:1320-1326
Catabolic inflammatory cytokines are prevalent in osteoarthritis (OA). The purpose of this study was to evaluate an autologous protein solution (APS) as a potential chondroprotective agent for OA therapy. APS was prepared from platelet-rich plasma (P
Publikováno v:
The Journal of Bone and Joint Surgery-American Volume. 91:1459-1470
Background: Demineralized bone matrix is an osteoinductive and osteoconductive material that is often used in orthopaedic surgery to induce bone formation. Autologous platelet-rich plasma, which contains proliferative and chemoattractant growth facto